PRA Health Sciences, Inc.
PRA Health Sciences, Inc., a leading name in the research and development services sector, is headquartered in the United States. Founded in 1976, the company has established itself as a key player in clinical research, offering a comprehensive range of services that span from Phase I to Phase IV clinical trials. With a strong presence in North America, Europe, and Asia, PRA Health Sciences is renowned for its innovative approach to drug development and patient engagement.
The company’s core offerings include clinical trial management, data analytics, and regulatory consulting, all designed to streamline the drug development process. PRA Health Sciences is distinguished by its commitment to quality and efficiency, which has earned it a prominent position in the global market. Notable achievements include numerous successful partnerships with pharmaceutical and biotechnology firms, solidifying its reputation as a trusted partner in advancing healthcare solutions.
+20 vs industry average
PRA Health Sciences, Inc.’s score of 49 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at PRA Health Sciences, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Reported emissions
Scope 3 accounts for ••• of total emissions.
PRA Health Sciences, Inc.'s reported carbon emissions
PRA Health Sciences, Inc., headquartered in the US and operating in the research and development services industry, reported total carbon emissions of approximately 31.3 million kg CO2e for the year 2019. Scope 1 emissions for that year were approximately 485,000 kg CO2e, and Scope 2 emissions stood at approximately 8.5 million kg CO2e, primarily from purchased electricity. Scope 3 emissions, dominated by business travel, reached approximately 22.4 million kg CO2e. In 2018, PRA Health Sciences, Inc. reported total emissions of approximately 29.9 million kg CO2e, with Scope 1 emissions at approximately 401,000 kg CO2e, Scope 2 at approximately 8.6 million kg CO2e, and Scope 3 at approximately 20.9 million kg CO2e. Looking back, in 2017, total emissions were approximately 29.6 million kg CO2e, comprising Scope 1 of around 425,000 kg CO2e, Scope 2 of approximately 9.2 million kg CO2e, and Scope 3 of about 20 million kg CO2e. For 2016, total emissions were approximately 32.4 million kg CO2e. Scope 1 emissions were around 412,000 kg CO2e, Scope 2 emissions were approximately 9.1 million kg CO2e, and Scope 3 emissions were approximately 22.9 million kg CO2e. In 2015, total emissions were approximately 25.7 million kg CO2e, with Scope 1 emissions at approximately 794,000 kg CO2e, Scope 2 at approximately 7.9 million kg CO2e, and Scope 3 at approximately 17 million kg CO2e. The most recent available data shows that in 2014, emissions data was disclosed for Scope 1 and Scope 2 only. Scope 1 emissions were approximately 778,650 kg CO2e, and Scope 2 emissions were approximately 4.2 million kg CO2e. PRA Health Sciences, Inc. has set ambitious climate commitments, aiming to reduce both its Scope 1 and Scope 2 emissions to near zero by the middle of this decade, specifically targeting the period between 2023 and 2025. It is important to note that PRA Health Sciences, Inc. is a current subsidiary of ICON Public Limited Company, and some of its climate initiatives, such as SBTi reduction targets, RTZ, and CDP disclosures, are cascaded from ICON Public Limited Company.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
PRA Health Sciences, Inc.’s Climate Goals (2030 & 2050)
2 goals2025
We aim to reduce our Scope 2 emissions to near zero by the m…
We aim to reduce our Scope 2 emissions to near zero by the middle of this decade.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
1 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative
Inherited from ICON Public Limited Company
Carbon Disclosure Project
Inherited from ICON Public Limited CompanyThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from ICON Public Limited CompanyRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project